Aktuellt
SENASTE
We point to trial progress and that Hansa is activating more centres which are essential at this stage of the launch. Hansa is also securing agreements of Idefirix funding, HTA submissions and can point to patients approaching treatment at nine select priority centres.
LÄS MER
